Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo
Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now includes a new line '2023 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers, and the page revision has been updated from v3.6.5 to v3.6.6 (the previous revision line was removed).SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedPlain Language Summary was removed from the study page, eliminating the layperson-friendly overview of the trial and its objectives.SummaryDifference0.0%

- Check39 days agoChange DetectedAn HTML error page was added, making the study record unavailable. Several core content sections and sponsor/IPD-related items were removed from the page, reducing the information available about the study.SummaryDifference17%

- Check53 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4. This indicates an internal update to the page's metadata rather than any changes to the study content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published revision of the record. This appears to be a small, internal version update with no visible changes to the study details or data.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer software patch for the study record; there are no described content changes in this update.SummaryDifference0.0%

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.